CFTR and amyotrophic lateral sclerosis: Enhancing facilitated transport has been of interest for several diseases, most prominently with cystic fibrosis transmembrane conductance regulator (CFTR) and cystic fibrosis but also with the glutamate transporters and amyotrophic lateral sclerosis [40,41,42].